(GBF) Bilfinger SE - Ratings and Ratios
Engineering, Maintenance, Construction, Decommissioning, Digital
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.31% |
| Yield on Cost 5y | 11.67% |
| Yield CAGR 5y | 6.30% |
| Payout Consistency | 90.4% |
| Payout Ratio | 47.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Value at Risk 5%th | 42.5% |
| Relative Tail Risk | -8.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.55 |
| Alpha | 156.25 |
| CAGR/Max DD | 2.93 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.491 |
| Beta | 0.232 |
| Beta Downside | 0.411 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.06% |
| Mean DD | 6.47% |
| Median DD | 5.17% |
Description: GBF Bilfinger SE January 11, 2026
Bilfinger SE (XETRA:GBF) is a German-based industrial services firm that delivers engineering, construction, maintenance, and digital solutions to process-industry clients across Europe, North America, and the Middle East. Its portfolio spans traditional plant services-such as turnaround management, rotating equipment, inspection, insulation, and corrosion protection-as well as newer energy-transition offerings, including carbon-capture-and-storage (CCS), hydrogen, wind, and hydropower projects, plus waste-recycling and wastewater-treatment services. The company also operates in the nuclear sector, providing new-build, de-commissioning, and radioactive-waste handling capabilities.
Key operating metrics (FY 2023) show an adjusted EBIT margin of roughly 6.5 % and an order backlog of €5.2 bn, indicating a moderate degree of revenue visibility into 2025. Bilfinger’s earnings are highly sensitive to cyclicality in the chemicals, oil-and-gas, and pharma sectors, which together account for about 70 % of revenue; a 1 % change in global industrial production is estimated to move EBITDA by ±0.3 %. The firm is also positioning itself for the European energy transition: its CCS and hydrogen service lines grew double-digit percentages YoY in 2023, and the segment now contributes ~4 % of total sales, a figure that management expects to reach 8–10 % by 2027. Capital-expenditure intensity remains low (≈2 % of revenue), giving Bilfinger flexibility to increase leverage if needed to fund growth.
For a deeper, data-driven assessment of Bilfinger’s valuation and risk profile, you may find the analyst tools on ValueRay useful for building a customized scenario model.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (185.8m TTM) > 0 and > 6% of Revenue (6% = 322.0m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 2.84pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.60% (prev 10.59%; Δ -2.99pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 350.0m > Net Income 185.8m (YES >=105%, WARN >=100%) |
| Net Debt (-102.7m) to EBITDA (371.7m) ratio: -0.28 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.24 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (37.1m) change vs 12m ago -1.36% (target <= -2.0% for YES) |
| Gross Margin 11.01% (prev 10.93%; Δ 0.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 156.6% (prev 143.5%; Δ 13.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 19.68 (EBITDA TTM 371.7m / Interest Expense TTM 15.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.01
| (A) 0.12 = (Total Current Assets 2.08b - Total Current Liabilities 1.67b) / Total Assets 3.46b |
| (B) 0.12 = Retained Earnings (Balance) 400.6m / Total Assets 3.46b |
| (C) 0.09 = EBIT TTM 305.0m / Avg Total Assets 3.43b |
| (D) 0.25 = Book Value of Equity 542.0m / Total Liabilities 2.15b |
| Total Rating: 2.01 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.98
| 1. Piotroski 7.0pt |
| 2. FCF Yield 7.01% |
| 3. FCF Margin 5.47% |
| 4. Debt/Equity 0.28 |
| 5. Debt/Ebitda -0.28 |
| 6. ROIC - WACC (= 10.25)% |
| 7. RoE 14.35% |
| 8. Rev. Trend 93.23% |
| 9. EPS Trend 69.11% |
What is the price of GBF shares?
Over the past week, the price has changed by +2.36%, over one month by +7.04%, over three months by +18.34% and over the past year by +165.44%.
Is GBF a buy, sell or hold?
What are the forecasts/targets for the GBF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 112 | -3.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 186.5 | 60.1% |
GBF Fundamental Data Overview January 10, 2026
P/E Trailing = 23.1111
P/S = 0.8
P/B = 3.2789
P/EG = -171.8
Revenue TTM = 5.37b EUR
EBIT TTM = 305.0m EUR
EBITDA TTM = 371.7m EUR
Long Term Debt = 175.2m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 179.1m EUR (from shortTermDebt, last quarter)
Debt = 365.9m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -102.7m EUR (from netDebt column, last quarter)
Enterprise Value = 4.19b EUR (4.29b + Debt 365.9m - CCE 468.6m)
Interest Coverage Ratio = 19.68 (Ebit TTM 305.0m / Interest Expense TTM 15.5m)
EV/FCF = 14.26x (Enterprise Value 4.19b / FCF TTM 293.7m)
FCF Yield = 7.01% (FCF TTM 293.7m / Enterprise Value 4.19b)
FCF Margin = 5.47% (FCF TTM 293.7m / Revenue TTM 5.37b)
Net Margin = 3.46% (Net Income TTM 185.8m / Revenue TTM 5.37b)
Gross Margin = 11.01% ((Revenue TTM 5.37b - Cost of Revenue TTM 4.78b) / Revenue TTM)
Gross Margin QoQ = 11.29% (prev 11.46%)
Tobins Q-Ratio = 1.21 (Enterprise Value 4.19b / Total Assets 3.46b)
Interest Expense / Debt = 1.34% (Interest Expense 4.90m / Debt 365.9m)
Taxrate = 24.90% (18.5m / 74.3m)
NOPAT = 229.1m (EBIT 305.0m * (1 - 24.90%))
Current Ratio = 1.24 (Total Current Assets 2.08b / Total Current Liabilities 1.67b)
Debt / Equity = 0.28 (Debt 365.9m / totalStockholderEquity, last quarter 1.30b)
Debt / EBITDA = -0.28 (Net Debt -102.7m / EBITDA 371.7m)
Debt / FCF = -0.35 (Net Debt -102.7m / FCF TTM 293.7m)
Total Stockholder Equity = 1.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.42% (Net Income 185.8m / Total Assets 3.46b)
RoE = 14.35% (Net Income TTM 185.8m / Total Stockholder Equity 1.29b)
RoCE = 20.75% (EBIT 305.0m / Capital Employed (Equity 1.29b + L.T.Debt 175.2m))
RoIC = 16.56% (NOPAT 229.1m / Invested Capital 1.38b)
WACC = 6.32% (E(4.29b)/V(4.66b) * Re(6.77%) + D(365.9m)/V(4.66b) * Rd(1.34%) * (1-Tc(0.25)))
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.71%
[DCF Debug] Terminal Value 86.95% ; FCFF base≈252.9m ; Y1≈312.0m ; Y5≈531.4m
Fair Price DCF = 366.9 (EV 13.55b - Net Debt -102.7m = Equity 13.65b / Shares 37.2m; r=6.32% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 69.11 | EPS CAGR: 10.73% | SUE: 0.27 | # QB: 0
Revenue Correlation: 93.23 | Revenue CAGR: 9.57% | SUE: 2.20 | # QB: 1
EPS next Year (2026-12-31): EPS=6.35 | Chg30d=+0.010 | Revisions Net=-1 | Growth EPS=+20.7% | Growth Revenue=+4.1%